Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaldo Capriles-Hulett

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Allergy and Clinical Immunology|July 13, 2010
A novel non-IgE-mediated pathway of mite-induced inflammationMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|December 5, 2014
[Common mistakes in the treatment of patients with anaphylaxis]Mario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
American Journal of Clinical Dermatology|November 26, 2002
NSAID-induced urticaria and angioedema: a reappraisal of its clinical managementMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2006
Oral mite anaphylaxis (pancake syndrome) also observed in childrenMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonesca
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 3, 2005
Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedemaMario Sánchez-Borges, Fernan Caballero-Fonseca, Arnaldo Capriles-Hulett
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 11, 2005
Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxibMario Sánchez-Borges, Fernan Caballero-Fonseca, Arnaldo Capriles-Hulett
Immunology and Allergy Clinics of North America|May 4, 2013
Aspirin-exacerbated cutaneous diseaseMario Sánchez-Borges, Fernan Caballero-Fonseca, Arnaldo Capriles-Hulett
American Journal of Therapeutics|November 16, 2004
Adverse reactions to selective cyclooxygenase-2 inhibitors (coxibs)Mario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
Expert Opinion on Drug Safety|August 23, 2005
Risk of skin reactions when using ibuprofen-based medicinesMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
The World Allergy Organization Journal|January 4, 2013
Asthma care in resource-poor settingsMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Allergy and Clinical Immunology|July 13, 2010
A novel non-IgE-mediated pathway of mite-induced inflammationMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|December 5, 2014
[Common mistakes in the treatment of patients with anaphylaxis]Mario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
American Journal of Clinical Dermatology|November 26, 2002
NSAID-induced urticaria and angioedema: a reappraisal of its clinical managementMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2006
Oral mite anaphylaxis (pancake syndrome) also observed in childrenMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonesca
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 3, 2005
Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedemaMario Sánchez-Borges, Fernan Caballero-Fonseca, Arnaldo Capriles-Hulett
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 11, 2005
Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxibMario Sánchez-Borges, Fernan Caballero-Fonseca, Arnaldo Capriles-Hulett
Immunology and Allergy Clinics of North America|May 4, 2013
Aspirin-exacerbated cutaneous diseaseMario Sánchez-Borges, Fernan Caballero-Fonseca, Arnaldo Capriles-Hulett
American Journal of Therapeutics|November 16, 2004
Adverse reactions to selective cyclooxygenase-2 inhibitors (coxibs)Mario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
Expert Opinion on Drug Safety|August 23, 2005
Risk of skin reactions when using ibuprofen-based medicinesMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
The World Allergy Organization Journal|January 4, 2013
Asthma care in resource-poor settingsMario Sánchez-Borges, Arnaldo Capriles-Hulett, Fernan Caballero-Fonseca
Pageof 4